Abstract
The NCCN Guidelines for Central Nervous System Cancers provide multidisciplinary recommendations for the clinical management of patients with cancers of the central nervous system. These NCCN Guidelines Insights highlight recent updates regarding the management of metastatic brain tumors using radiation therapy. Use of stereotactic radiosurgery (SRS) is no longer limited to patients with 3 or fewer lesions, because data suggest that total disease burden, rather than number of lesions, is predictive of survival benefits associated with the technique. SRS is increasingly becoming an integral part of management of patients with controlled, low-volume brain metastases.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1517-1523 |
| Number of pages | 7 |
| Journal | JNCCN Journal of the National Comprehensive Cancer Network |
| Volume | 12 |
| Issue number | 11 |
| DOIs | |
| State | Published - Nov 1 2014 |
ASJC Scopus subject areas
- Oncology
Fingerprint
Dive into the research topics of 'Central nervous system cancers, Version 2.2014: Featured updates to the NCCN guidelines'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS